Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
[11 C]‐(+)‐PHNO (4‐propyl‐9‐hydroxynaphthoxazine) is a new agonist radioligand that provides a unique opportunity to measure the high‐affinity states of the D 2 receptors (D 2‐high) using positron emission tomography (PET). Here we report on the distribution, displaceablity, specificity and modeling of [11 C]‐(+)‐PHNO and compare it with the well characterized antagonist D 2 radioligand, [11 C]raclopride, in cat. [11 C]‐(+)‐PHNO displayed high uptake in striatum with a mean striatal binding potential (BP) of 3.95 ± 0.85. Pre‐treatment with specific D 1 (SCH23390), D 2 (raclopride, haloperidol) and D 3 receptor (SB‐277011) antagonists indicated that [11 C]‐(+)‐PHNO binding in striatum is specific to D 2 receptors. Within‐subject comparisons showed that [11 C]‐(+)‐PHNO BP in striatum was almost 2.5‐fold higher than that measured with [11 C]‐(–)‐NPA ([11 C]‐(–)‐N‐propyl‐norapomorphine). Comparison of the dose‐effect of amphetamine (0.1, 0.5 and 2 mg/kg; i.v.) showed that [11 C]‐(+)‐PHNO was more sensitive to the dopamine releasing effect of amphetamine than [11 C]raclopride. Amphetamine induced up to 83 ± 4% inhibition of [11 C]‐(+)‐PHNO BP and only up to 56 ± 8% inhibition of [11 C]raclopride BP. Scatchard analyses of [11 C]‐(+)‐PHNO and [11 C]raclopride bindings in two cats showed that the B max obtained with the agonist (29.6 and 32.9 pmol/mL) equalled that obtained with the antagonist (30.6 and 33.4 pmol/mL). The high penetration of [11 C]‐(+)‐PHNO in brain, its high signal‐to‐noise ratio, its favorable in vivo kinetics and its high sensitivity to amphetamine shows that [11 C]‐(+)‐PHNO has highly suitable characteristics for probing the D 2‐high with PET.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Sun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99 · cited 1×
“…following d-amphetamine is also seen with antagonist D2 radioligands such as [ 11C]raclopride (Carson et al. 2001; Cardenas et al. 2004) and [123I]IBZM (Laruelle et al. 1997), and has been proposed to reflect a DA-promoted internalization of D2 receptors (Sun et al. 2003; Ginovart et al. 2004a).”
BackgroundSelf-citationOral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET
Cárdenas, L., Houle, S., Kapur, S., & Busto, U. E. (2004) · Synapse · doi:10.1002/syn.10282 · Cited by 63 · cited 1×
“…reduction in radioligand binding following d-amphetamine is also seen with antagonist D2 radioligands such as [ 11C]raclopride (Carson et al. 2001; Cardenas et al. 2004) and [123I]IBZM (Laruelle et al. 1997), and has been proposed to reflect a DA-promoted internalization of D2 receptors (Sun et…”
BackgroundSelf-citation
Cited by
Increased stress-induced dopamine release in psychosis
Mizrahi, R., Addington, J., Rusjan, P. M., Suridjan, I., Ng, A., Boileau, I., Pruessner, J. C., Remington, G., Houle, S., & Wilson, A. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.009 · Cited by 277
Self-citationAll Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
Seeman, P. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00162.x · Cited by 228
“Intravenous amphetamine, for example, inhibited the binding of agonists (methoxy-NPA or radioactive (+)PHNO) more than it inhibited the binding of an antagonist (raclopride) [57,58].”
BackgroundSelf-citationConsiderations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
W. Pike, V. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160418114826 · Cited by 195
Cho, S. S., Koshimori, Y., Aminian, K., Obeso, I., Rusjan, P., Lang, A. E., Daskalakis, Z. J., Houle, S., & Strafella, A. P. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.211 · Cited by 112
Self-citationWilleit, M., Ginovart, N., Graff, A., Rusjan, P., Vitcu, I., Houle, S., Seeman, P., Wilson, A. A., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301400 · Cited by 107
“…maximal reduction of 68% for [11C]raclopride BPs as compared to 96% for [11C]-( + )-PHNO BPs (Ginovart et al, 2006a), and direct comparisons between [11C]NPA and [11C]-( + )-PHNO show that the latter ligand is more sensitive to endogenous dopamine than the former one (Ginovart et al, 2006a).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Ginovart, N., Galineau, L., Willeit, M., Mizrahi, R., Bloomfield, P. M., Seeman, P., Houle, S., Kapur, S., & Wilson, A. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-04-05
- Volume
- 97
- Issue
- 4
- Pages
- 1089-1103
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1969866636
- Cited by
- 146
- References
- 3
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography. https://app.cochat.ai/papers/10.1111/j.1471-4159.2006.03840.x
- The paper
- Ginovart, N., Galineau, L., Willeit, M., Mizrahi, R., Bloomfield, P. M., Seeman, P., Houle, S., Kapur, S., & Wilson, A. A. (2006). Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2006.03840.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.